Rockefeller Capital Management L.P. Vyne Therapeutics Inc. Transaction History

Rockefeller Capital Management L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$0.12 - $4.91 $156 - $6,383	-1,300 Reduced 95.31%	64 $0
Q2 2022 Aug 12, 2022	BUY	$0.37 - $0.71 $7 - $14	20 Added 1.49%	1,364 $0
Q1 2022 May 13, 2022	BUY	$0.5 - $1.15 $15 - $34	30 Added 2.28%	1,344 $0
Q3 2021 Nov 12, 2021	BUY	$1.39 - $3.47 $19 - $48	14 Added 1.08%	1,314 $1,000
Q2 2021 Aug 10, 2021	BUY	$3.24 - $6.92 $4,212 - $8,996	1,300 New	1,300 $4,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $179M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.